Your browser doesn't support javascript.
loading
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study.
Farroni, Chiara; Aiello, Alessandra; Picchianti-Diamanti, Andrea; Laganà, Bruno; Petruccioli, Elisa; Agrati, Chiara; Garbuglia, Anna Rosa; Meschi, Silvia; Lapa, Daniele; Cuzzi, Gilda; Petrone, Linda; Vanini, Valentina; Salmi, Andrea; Altera, Anna Maria Gerarda; Repele, Federica; Grassi, Germana; Bettini, Aurora; Vita, Serena; Mariano, Andrea; Damiani, Arianna; Infantino, Maria; Grossi, Valentina; Manfredi, Mariangela; Niccoli, Laura; Puro, Vincenzo; Rosa, Roberta Di; Salemi, Simonetta; Sesti, Giorgio; Scolieri, Palma; Bruzzese, Vincenzo; Benucci, Maurizio; Cantini, Fabrizio; Nicastri, Emanuele; Goletti, Delia.
Afiliación
  • Farroni C; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Aiello A; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Picchianti-Diamanti A; Department of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, Rome, Italy.
  • Laganà B; Department of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, Rome, Italy.
  • Petruccioli E; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Agrati C; Laboratory of Cellular Immunology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Garbuglia AR; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Meschi S; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Lapa D; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Cuzzi G; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Petrone L; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Vanini V; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy; Unità Operativa Semplice (UOS) Professioni Sanitarie Tecniche, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Salmi A; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Altera AMG; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Repele F; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Grassi G; Laboratory of Cellular Immunology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Bettini A; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Vita S; Clinical Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Mariano A; Clinical Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Damiani A; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.
  • Infantino M; Immunology and Allergology Laboratory, S. Giovanni di Dio Hospital, Azienda USL-Toscana Centro, Florence, Italy.
  • Grossi V; Immunology and Allergology Laboratory, S. Giovanni di Dio Hospital, Azienda USL-Toscana Centro, Florence, Italy.
  • Manfredi M; Immunology and Allergology Laboratory, S. Giovanni di Dio Hospital, Azienda USL-Toscana Centro, Florence, Italy.
  • Niccoli L; Rheumatology Department, Hospital of Prato, Prato, Italy.
  • Puro V; UOC Emerging Infections and Centro di Riferimento AIDS (CRAIDS), National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Rosa RD; Department of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, Rome, Italy.
  • Salemi S; Department of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, Rome, Italy.
  • Sesti G; Department of Clinical and Molecular Medicine, "Sapienza" University, S. Andrea University Hospital, Rome, Italy.
  • Scolieri P; UOC di Medicina e Rete Reumatologica, Ospedale Nuovo Regina Margherita, Rome, Italy.
  • Bruzzese V; UOC di Medicina e Rete Reumatologica, Ospedale Nuovo Regina Margherita, Rome, Italy.
  • Benucci M; Rheumatology Unit, S. Giovanni di Dio Hospital, Azienda USL-Toscana Centro, Florence, Italy.
  • Cantini F; Rheumatology Department, Hospital of Prato, Prato, Italy.
  • Nicastri E; Clinical Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
  • Goletti D; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy. Electronic address: delia.goletti@inmi.it.
Int J Infect Dis ; 125: 195-208, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36328289
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Artritis Reumatoide / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Artritis Reumatoide / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Italia